Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

NCT05532475 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT05532475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
Lead sponsor
Kasr El Aini Hospital
Phase
Observational
Overall status
Completed
Start date
March 12, 2022
Completion date
October 30, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal vein occlusion